CIK 0001595097
- Non-accelerated filer
- Smaller reporting company
Corbus Pharmaceuticals Holdings, Inc.
Sign in to watch- Ticker
- CRBP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 464348039
- Phone
- +1 617-963-0103
- Business address
- 500 RIVER RIDGE DRIVE, NORWOOD, MA, 02062
- Former names
- SAV Acquisition Corp
- 4/A Open-market buy Director bought 5,000 shares at $6.90 ($34,500)
- 4 Grant or award Director acquired 5,000 shares (grant or award)
- 4 Open-market buy Chief Financial Officer bought 1,500 shares at $7.04 ($10,560)
- 4 Open-market buy Chief Medical Officer bought 2,836 shares at $7.00 ($19,852)
- 4 Open-market buy Director bought 10,000 shares at $7.08 ($70,800)
- 4 Open-market buy Chief Executive Officer bought 1,000 shares at $7.17 ($7,169)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Chief Medical Officer bought 2,479 shares at $6.05 ($14,998)
- 4 Open-market buy Chief Executive Officer bought 1,695 shares at $6.00 ($10,170)
- 4 Open-market buy Chief Financial Officer bought 2,500 shares at $5.91 ($14,775)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Chief Financial Officer bought 3,300 shares at $6.14 ($20,262)
- 4 Open-market buy Director bought 500 shares at $6.23 ($3,115)
- 4 Open-market buy Director bought 3,400 shares at $6.18 ($21,012)
- 4 Open-market buy Director bought 5,000 shares at $6.15 ($30,741)
- 4 Open-market buy Chief Medical Officer bought 2,435 shares at $6.12 ($14,905)
Page 11 of 17 · 340 filings